Checkmate Pharmaceuticals OverviewCheckmate Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for CMPI.
Quarterly Other Income/Expense
-$19000.00
↓ 135.85% YoY
As of Mar 31, 2022
Annual Other Income/Expense (TTM)
-$20000.00
↓ 174.07% YoY
Trailing 12 months ending Mar 31, 2022